Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jorge Guzmán-Huesca"'
Autor:
Jordi Guzmán‐Casta, Sonia Carrasco‐CaraChards, Jorge Guzmán‐Huesca, Carla Paola Sánchez‐Ríos, Rodrigo Riera‐Sala, José Fabián Martínez‐Herrera, Erika Sagrario Peña‐Mirabal, Diana Bonilla‐Molina, Jorge Arturo Alatorre‐Alexander, Luis Manuel Martínez‐Barrera, Jerónimo Rafael Rodríguez‐Cid
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Abstract Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for mal
Externí odkaz:
https://doaj.org/article/7bd83ef32c1c460d930b9e6993ead98d
Autor:
Jeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards, Jorge Guzmán-Huesca, Rodrigo Riera-Sala, Carla Paola Sánchez-Ríos, Mayte Cruz-Zermeño, Alec Seidman-Sorsby, Ivan de Jesús Rodríguez-Zea, Jorge Arturo Alatorre-Alexander, Luis Manuel Martínez-Barrera, Patricio Javier Santillán-Doherty, Aminadab Godina-Flores, Victoria Imaz-Olguin, Ricardo Sosa-Sánchez, Dan Green-Renner
Publikováno v:
Journal of cancer research and clinical oncology.
Thoracic sarcomas are rare malignancies, with limited data for unresectable/advanced scenarios. Our goal is to provide insights of a three-drug chemotherapy regimen improving patient survival compared to standard regimens.Retrospective cohort analysi
Autor:
Jordi Guzmán-Casta, Rodrigo Riera-Sala, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez-Cid, Carla Paola Sánchez-Ríos, Diana Bonilla-Molina, Sonia Carrasco-CaraChards, Erika Sagrario Peña-Mirabal, Jorge Arturo Alatorre-Alexander, Jorge Guzmán-Huesca, José Fabián Martínez-Herrera
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for malignant pl